申请人:GENFIT
公开号:US20150038503A1
公开(公告)日:2015-02-05
The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the activation of Rev-Erb has therapeutic effects, for instance in inflammatory and circadian rhythm-related disorders or cardiometabolic diseases.
本发明提供了新型的6-取代[1,2,4]三唑并[4,3-b]吡啶嗪,这些化合物是Rev-Erb激动剂。这些化合物及其含有的药物组合物是治疗任何需要Rev-Erb激活具有治疗效果的疾病的适当手段,例如炎症和昼夜节律相关疾病或心脏代谢疾病。